Multiple Myeloma Research Foundation
The Multiple Myeloma Research Foundation (MMRF) leads the way in accelerating a cure for each and every myeloma patient. One important initiative is the MMRF CureCloud ® . This longitudinal IRB-approved research study includes the first at-home genomic testing program for multiple myeloma patients. Our goal: harness a vast amount of genomic, clinical—and eventually—patient immune and other kids of data--to accelerate research into smarter treatments for every patient. The more patients that enroll in the study, the more we learn about each myeloma genetic subtype. Ultimately, this research study will inform personalized treatment options to consider with your patients.
The MMRF CureCloud ® is a longitudinal, IRB-approved research study which includes the first at-home genomic testing program for multiple myeloma patients. Our goal: harness a vast amount of genomic, clinical—and eventually—patient immune and other kids of data, to accelerate research into smarter treatments for every patient. The more patients that enroll in the study, the more we learn about each myeloma genetic subtype. Ultimately, this research study will inform personalized treatment options to consider with your patient.